Alpha Cognition (ACOG) FCF Margin (2025)

Alpha Cognition (ACOG) posted quarterly FCF Margin of 252.55% for Q4 2025, down 33.74% quarter-over-quarter from 188.84% in Q3 2025.

Alpha Cognition (ACOG) FCF Margin (2025) Analysis & Trends

Alpha Cognition's FCF Margin history runs 1 years deep, the most recent figure standing at 252.55% for Q4 2025.

In Q4 2025, FCF Margin changed N/A year-over-year to 252.55%; the TTM figure through Dec 2025 stood at 202.28% (changed N/A YoY), while the FY2025 annual figure was 202.28%, changed N/A from the prior year.
FCF Margin for Q4 2025 stood at 252.55%, down from 188.84% in the prior quarter.
The five-year high for FCF Margin was 71.96% in Q1 2025, with the low at 370.87% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	30.39%
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	13.35%
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-388.28%
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	25.68%
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	22.62%
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-22.35%
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	70.82%
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	41.07%
10	Alpha Cognition	209.03 Mn	167.59 Mn	5.70 Mn	-

Download Data